Here, we studied T cell responses to IL12-MSA alone or in combination with IL2-MSA in mice with KP lung tumors to better understand cytokine-mediated T cell activation and tumor control of ICB-resistant NSCLC. This evidence concerns the gene IL2 and neoplasm.